Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatitis C virus (HCV) eradication by direct-acting antiviral agents (DAAs) reduces de novo hepatocellular carcinoma incidence in cirrhosis; however, contrasting evidence on higher incidence of hepatocellular carcinoma (HCC) was reported in patients previously treated for HCC. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Giovannini, Catia, Fornari, Francesca, Indio, Valentina, Trerè, Davide, Renzulli, Matteo, Vasuri, Francesco, Cescon, Matteo, Ravaioli, Matteo, Perrucci, Alessia, Astolfi, Annalisa, Piscaglia, Fabio, Gramantieri, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565876/
https://www.ncbi.nlm.nih.gov/pubmed/32961688
http://dx.doi.org/10.3390/cancers12092674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565876/
https://www.ncbi.nlm.nih.gov/pubmed/32961688
http://dx.doi.org/10.3390/cancers12092674

Ejemplares similares